Table 2.
Demographics and practice setting of survey respondents (N = 131)
| Variable | n (%) |
|---|---|
| GI or Hepatology board-certified | 126 (96.2) |
| Years of practice post-fellowship: 0–10 y | 59 (45.0) |
| 11–20 y | 38 (29.0) |
| >20 y | 34 (26.0) |
| UNOS regions: 1 (3.7%a) | 4 (3.2) |
| 2 (11.5%a) | 15 (11.5) |
| 3 (16.2%a) | 11 (8.4) |
| 4 (10.4%a) | 7 (5.3) |
| 5 (15.8%a) | 16 (12.2) |
| 6 (2.8%a) | 4 (3.1) |
| 7 (7.8%a) | 34 (26.0) |
| 8 (6.4%a) | 7 (5.3) |
| 9 (5.7%a) | 10 (7.6) |
| 10 (9.9%a) | 10 (7.6) |
| 11 (9.8%a) | 13 (9.9) |
| Male sex | 90 (68.7) |
| Age range: 25–35 y | 12 (9.2) |
| 36–45 y | 57 (43.5) |
| 46–55 y | 29 (22.1) |
| 56–65 y | 24 (18.3) |
| >65 y | 7 (5.3) |
| Race/ethnicity: non-Hispanic White | 72 (55.0) |
| Asian | 31 (23.7) |
| Hispanic | 15 (11.5) |
| Other | 13 (9.9) |
| Hospital setting: university-based or -affiliated | 118 (90.1) |
| Community | 10 (7.6) |
| Number of liver transplants in 2019: 1–40 | 23 (17.6) |
| 40–80 | 28 (21.4) |
| >80 | 80 (61.0) |
| Average number of patients with liver disease per weekb | 33.5 ± 16.6 |
| Average number of patients with ALD per weekb | 11.8 ± 7.6 |
| Average number of patients with active AUD per weekb | 6.0 ± 5.5 |
aPercent of overall liver transplants in the United States in 2019.
bEvaluated by each respondent.
ALD, alcohol-associated liver disease; AUD, alcohol use disorder; GI, gastroenterology; UNOS, United Network for Organ Sharing.